Service de pédiatrie A, American Memorial Hospital, CHU de Reims, France.
Diabetes Metab. 2011 Feb;37(1):59-63. doi: 10.1016/j.diabet.2010.07.007. Epub 2010 Dec 13.
Insulin pump therapy is an emerging option in the management of type 1 diabetes (T1D), but it often remains unused. For this reason, in 2007, a French national survey was carried out to update the frequency of insulin pump use in the paediatric population compared with a previous survey done in 2001.
The present survey was performed in hospital departments involved in paediatric diabetes management (n = 67) and in adult departments involved in adolescent diabetes management (n = 113). The number of T1D children (age < 18 years) treated in each department, with or without the use of an insulin pump, and the number of insulin pump therapies initiated during the previous year were collected.
A total of 60 paediatric and 28 adult centres responded, involving 9073 T1D children and adolescents (93% in paediatric departments). Of these patients, 1461 (16%) were treated by insulin pump, 89% of which were managed in paediatric centres. However, pump use was more frequent in adult than in paediatric centres (32% versus 18%, respectively). Also, 38% of insulin pumps were initiated during the year prior to the survey. In addition, in 2001, 140 children were treated with insulin pump in 13 paediatric centres (versus 56 centres in 2007).
The number of centres using insulin pump therapy for diabetic children and the number of children treated by insulin pump were increased fourfold and 10-fold, respectively, from 2001 to 2007, indicating greater access to pump therapy in the French paediatric population. The present survey is still ongoing to evaluate the decision-making criteria that influence the initiation of insulin pump therapy in T1D paediatric patients.
胰岛素泵治疗是 1 型糖尿病(T1D)管理的新兴选择,但它经常未被使用。出于这个原因,2007 年进行了一项法国全国性调查,以更新与 2001 年之前的调查相比,儿科人群中胰岛素泵使用的频率。
本调查在参与儿科糖尿病管理的医院科室(n=67)和参与青少年糖尿病管理的成人科室(n=113)进行。收集每个科室中接受或不接受胰岛素泵治疗的 T1D 儿童(年龄<18 岁)的数量,以及前一年开始的胰岛素泵治疗数量。
共有 60 个儿科和 28 个成人中心做出回应,涉及 9073 名 T1D 儿童和青少年(93%在儿科科室)。这些患者中,1461 人(16%)接受胰岛素泵治疗,其中 89%在儿科中心管理。然而,泵的使用在成人科室比儿科科室更为常见(分别为 32%和 18%)。此外,38%的胰岛素泵是在调查前一年开始使用的。此外,2001 年,13 个儿科中心有 140 名儿童接受胰岛素泵治疗(而 2007 年则有 56 个中心)。
从 2001 年到 2007 年,使用胰岛素泵治疗糖尿病儿童的中心数量和接受胰岛素泵治疗的儿童数量分别增加了四倍和十倍,表明法国儿科人群获得泵治疗的机会增加。目前的调查仍在进行中,以评估影响 T1D 儿科患者开始胰岛素泵治疗的决策标准。